Sort   by:  
 Page size 
Proteomicshuman nk cell line LC-MSMS - Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
To identify protein binding partners of wild-type or Gαq T96S mutants using immunoprecipitation coupled to mass spectrometry.
ORGANISM(S): Homo sapiens (Human) 
2019-09-25 | PXD013285 | Pride
Lc-msms Nk cell line Human 
UnknownCombination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.
Not available
S-EPMC11369195 | biostudies-literature
ProteomicsBmori - Cocoon, SC (Zhangetal.,plosone2015)
abundance based on Spectral counting, Interaction consistency score: 1.0, Coverage: 2
ORGANISM(S): 7091 
2015-00-00 | 1004366984 | PAXDB
GenomicsUK_RCC_GWAS
Renal cell carcinoma (RCC) cases comprised adult patients with histologically proven RCC were collected through two sources within the UK. First, 856 cases from SORCE, a MRC collection of surgically treated RCC cases ascertained through UK clinical oncology centres. Second, 189 RCC cases collected t...
EGAD00010002310 | EGA
GenomicsUK renal cancer samples genotyped on Illumina OmniExpress BeadChip
Renal cell carcinoma (RCC) cases comprised adult patients with histologically proven RCC were collected through two sources within the UK. First, 856 cases from SORCE, a MRC collection of surgically treated RCC cases ascertained through UK clinical oncology centres. Second, 189 RCC cases collected t...
EGAS00001002336 | EGA
GenomicsUK RCC DAC
Data Access Committee EGAC00001002629
EGAC00001002629 | EGA
GenomicsCancer Genetic Markers of Susceptibility (CGEMS) Breast Cancer Genome-Wide Association Study (GWAS) - Primary Scan (Stage 1) - Nurses' Health Study

The Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer genome-wide association study (GWAS) included genotyping 528,173 SNPs (Illumina HumanHap550) in 1,145 postmenopausal women of European ancestry with invasive breast cancer and 1,142 controls from the Nurses' Health Study (...

phs000147.v1.p1 | EGA
GenomicsCancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer Genome-Wide Association Study (GWAS) - Primary Scan (Stage 1) - PLCO Screening Trial

The Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer genome-wide association study (GWAS) included genotyping approximately 550,000 SNPs (Phase 1A with HumanHap300 and Phase 1B HumanHap240, both from Illumina, San Diego, CA) in 1,172 prostate cancer patients and 1,157 controls...

phs000207.v1.p1 | EGA
GenomicsA Genome-Wide Association Study of Lung Cancer Risk

Three genetic loci for lung cancer risk have been identified by genome-wide association studies (GWAS), but inherited susceptibility to specific histologic types of lung cancer is not well established. We conducted a GWAS of lung cancer and its major histologic types genotyping 515,922 single n...

phs000336.v1.p1 | EGA
ProteomicsIntegrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention
The label-free methods of proteomic combined with metabolomics were applied to explore the mechanisms of Cryptotanshinone intervention in rats with acne. These results propose action mechanisms for the use of CPT in acne, as a safe and potential new drug.
ORGANISM(S): Rattus Rattus 
2021-07-12 | PXD027219 |
Sort   by:  
 Page size